<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7122247/results/search/test_trace/results.xml">
  <result pre="Host proteases may also contribute to the pathogenicity of virus" exact="infection" post="by activating proinflammatory cytokines. For some coronaviruses, human proteases"/>
  <result pre="small-molecule inhibitors of host proteases have been approved for the" exact="treatment" post="of virus infections, so far. Keywords Antiviral drugs Protease"/>
  <result pre="racecadotril is approved as an antidiarrheal drug. Despite limited use," exact="treatment" post="of high blood pressure is also possible with aliskiren,"/>
  <result pre="gliptins are a class of oral hypoglycemic drugs for the" exact="treatment" post="of diabetes mellitus type 2 targeting the serine protease"/>
  <result pre="is the nitrile derivative odanacatib, which was developed for the" exact="treatment" post="of osteoporosis. Based on a clinical phase III trial,"/>
  <result pre="cultures of chick embryo cells could be strongly increased after" exact="treatment" post="with exogenous trypsin, which cleaves substrates after basic residues"/>
  <result pre="and TMPRSS4-/- knockout mice reduced H3N2 spread and signs of" exact="infection" post="in lung, suggesting that both proteases are involved (Kuhn"/>
  <result pre="as cartoon in green. Only the aprotinin residues in direct" exact="contact" post="to the trypsin surface (Pro13-Cys-Lys-Ala-Arg17 and Cys38-Arg39) are shown"/>
  <result pre="was associated with increased numbers of deaths as compared to" exact="treatment" post="with standard antifibrinolytics (Fergusson et al. 2008). As nonhuman"/>
  <result pre="of the S1 pocket of matriptase but forms no direct" exact="contact" post="to its carboxyl group. It also interacts with the"/>
  <result pre="aprotinin has been developed and approved in Russia for the" exact="treatment" post="of mild-to-moderate influenza infections (Zhirnov et al. 2011). It"/>
  <result pre="and antibodies is steadily increasing and meanwhile well established, a" exact="treatment" post="with synthetic, small-molecule drugs offers significant advantages. They can"/>
  <result pre="allergic reactions. In initial studies a weak antiviral effect after" exact="treatment" post="with ECA (5, ε-aminocaproic acid, Fig. 11.4) was observed"/>
  <result pre="the S1 site and comes in close van der Waals" exact="contact" post="to the P1 phenyl ring (Fig. 11.7) above the"/>
  <result pre="hepatocyte growth factor activator (HGFA) have been prepared for tumor" exact="treatment" post="or regulation of iron overload but were not further"/>
  <result pre="(Baron et al. 2013; Meyer et al. 2013). For instance," exact="treatment" post="with 50 μM of compound 21 inhibited the multiple"/>
  <result pre="were developed to address the TTSPs as targets for tumor" exact="treatment" post="(Goswami et al. 2015; Kang et al. 2013; Lucas"/>
  <result pre="atoms in green and are labeled. Water molecules in direct" exact="contact" post="to the inhibitor are provided as red spheres, polar"/>
  <result pre="of the above-described inhibitors could also be suitable for the" exact="treatment" post="of HPIV infections. With other paramyxoviruses, such as measles"/>
  <result pre="furin or cathepsin L inhibitors should be suitable for the" exact="treatment" post="of these virus infections. The spike (S) surface protein"/>
  <result pre="in Calu-3 airway epithelial cells was achieved by a combination" exact="treatment" post="with the broad-spectrum serine protease inhibitor camostat (8) (Fig."/>
  <result pre="replication suggesting that the endosomal pathway is disadvantageous for HCoV-229E" exact="infection" post="in humans. Based on these results, the authors suggested"/>
  <result pre="of the Kunitz-type that are likely to inhibit furin, because" exact="treatment" post="with IαIp provided a significant protection against anthrax toxin"/>
  <result pre="binding pocket is not addressed Reduction of peptide bonds by" exact="treatment" post="of their amide precursors with borane-tetrahydrofuran provided a series"/>
  <result pre="One approach to find new nonpeptidic furin inhibitors is the" exact="testing" post="of compounds from natural sources. An example of this"/>
  <result pre="from natural sources. An example of this attempt is the" exact="screening" post="of the chemical constituents of the medicinally used plant"/>
  <result pre="almost equipotent. The CMK derivatives were able to block the" exact="infection" post="of lymphocytic choriomeningitis virus (LCMV) and chimeras of LCMV"/>
  <result pre="plasma cholesterol and triglycerides (Hay et al. 2007). Based on" exact="screening" post="results, improved derivatives were prepared. The most potent compound"/>
  <result pre="no escape variants could be detected during or after the" exact="treatment" post="with this SKI-1/S1P inhibitor. These studies were extended to"/>
  <result pre="more than 50 clinical trials with metalloprotease inhibitors for the" exact="treatment" post="of various cancers failed, their broad anti-inflammatory potential has"/>
  <result pre="al. 2013). Consequently, no antiviral effect could be observed after" exact="treatment" post="of MERS-CoV-infected cells with active-site-directed DPP4 inhibitors. Moreover, the"/>
  <result pre="only inhibitors addressing viral proteases have been approved for the" exact="treatment" post="of certain virus infections. A huge arsenal of excellent"/>
  <result pre="against host proteases has been developed in the past for" exact="treatment" post="of chronic diseases, such as hypertension, diabetes, risk of"/>
  <result pre="inhibitors or their analogues could still be suitable for short-term" exact="treatment" post="of acute life-threatening infectious diseases, without being hampered by"/>
  <result pre="inhibitor could be tolerable or even advantageous for the special" exact="treatment" post="of infectious disease, although selective drugs are usually preferred"/>
  <result pre="targetNat Rev Cancer2004434936010.1038/nrc136115122206 Al-HoraniRADesaiURRecent advances on plasmin inhibitors for the" exact="treatment" post="of fibrinolysis-related disordersMed Res Rev2014341168121610.1002/med.2131524659483 AndersonEDThomasLHayflickJSThomasGInhibition of HIV-1 gp160-dependent"/>
  <result pre="potent inhibitors of proprotein convertase furin as potential drugs for" exact="treatment" post="of infectious diseasesJ Biol Chem2012287219922200310.1074/jbc.M111.33264322539349 BertramSGlowackaIBlazejewskaPSoilleuxEAllenPDanischSSteffenIChoiSYParkYSchneiderHet al.TMPRSS2 and TMPRSS4"/>
  <result pre="and susceptibility to protease inhibitorsJ Virol2010845605561410.1128/JVI.00140-1020237084 Böttcher-FriebertshäuserESteinDAKlenkHDGartenWInhibition of Influenza virus" exact="infection" post="in human airway cell cultures by an antisense peptide-conjugated"/>
  <result pre="activating host cell proteases provide promising drug targets for the" exact="treatment" post="of influenza A and B virus infectionsVaccine2012307374738010.1016/j.vaccine.2012.10.00123072892 Böttcher-FriebertshäuserEKlenkHDGartenWActivation of"/>
  <result pre="Biophys Res Commun19672950851410.1016/0006-291X(67)90513-X16496527 ChenYShiotaMOhuchiMTowatariTTashiroJMurakamiMYanoMYangBKidoHMast cell tryptase from pig lungs triggers" exact="infection" post="by pneumotropic Sendai and influenza A viruses. Purification and"/>
  <result pre="progress in the development of HIV-1 protease inhibitors for the" exact="treatment" post="of HIV/AIDSJ Med Chem2016595172520810.1021/acs.jmedchem.5b0169726799988 GiererSBertramSKaupFWrenschFHeurichAKramer-KuhlAWelschKWinklerMMeyerBDrostenCet al.The spike protein of"/>
  <result pre="peptidases 5 and 12J Biol Chem2013288173991740710.1074/jbc.M112.44036223612974 HamiltonBSChungCCyphersSYRinaldiVDMarcanoVCWhittakerGRInhibition of influenza virus" exact="infection" post="and hemagglutinin cleavage by the protease inhibitor HAI-2Biochem Biophys"/>
  <result pre="a brief review of past pharmacological strategies for heart failure" exact="treatment" post="and future directionsCardiol J20162359159810.5603/CJ.a2016.006327665860 JeanFStellaKThomasLLiuGXiangYReasonAJThomasGalpha1-Antitrypsin Portland, a bioengineered serpin"/>
  <result pre="derivatives as TMPRSS4 inhibitorsBioorg Med Chem Lett2013231748175110.1016/j.bmcl.2013.01.05523414802 KawaseMShiratoKvan der HoekLTaguchiFMatsuyamaSSimultaneous" exact="treatment" post="of human bronchial epithelial cells with serine and cysteine"/>
  <result pre="Discov20161566927681786 MurakamiMTowatariTOhuchiMShiotaMAkaoMOkumuraYParryMAKidoHMini-plasmin found in the epithelial cells of bronchioles triggers" exact="infection" post="by broad-spectrum influenza A viruses and Sendai virusEur J"/>
  <result pre="and provide protection against experimental anthrax intoxicationInfect Immun2005735101510510.1128/IAI.73.8.5101-5105.200516041026 OvcharenkoAVZhirnovOPAprotinin aerosol" exact="treatment" post="of influenza and paramyxovirus bronchopneumonia of miceAntiviral Res19942310711810.1016/0166-3542(94)90038-87511880 PajuASorsaTTervahartialaTKoivunenEHaglundCLeminenAWahlströmTSaloTStenmanU-HThe"/>
  <result pre="of ectopic trypsins in the myocardium by influenza A virus" exact="infection" post="triggers acute myocarditisCardiovasc Res20118959560310.1093/cvr/cvq35821084314 PasquatoAPullikotilPAsselinMCVacatelloMPaolilloLGhezzoFBassoFDi BelloCDettinMSeidahNGThe proprotein convertase SKI-1/S1P."/>
 </snippets>
</snippetsTree>
